Combined HRT users 'twice as likely to develop breast cancer'

Women who use a certain type of hormone replacement therapy (HRT) are twice as likely to develop breast cancer as those who do not use any form of HRT at all, research showed today.

The study of more than one million participants found that post menopausal women using the combined oestrogen-progestagen treatment were at a greater risk than those using other types of HRT.